source
- GSK lung cancer drug gets speedy approval following $10.6B dealThe clearance is GSK’s first for a lung cancer medicine and the latest step forward in a yearslong push by the British drugmaker into oncology.BioPharma Dive · 8d ago↗ source
- FDA swiftly puts Makary era in the rearview mirrorAs the White House mulls a pick to lead the FDA, the Trump administration has been washing away the mark of former Commissioner Marty Makary, in a refresh that includes everything from reconsidered…Endpoints · 8d ago↗ source
- Former FDA cancer chief Pazdur says the agency should restructureRichard Pazdur, who spent more than two decades leading the FDA’s cancer drug reviews, said the agency has a “golden opportunity” to restructure after being struck last year by the Trump administra…